These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27618100)

  • 1. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network.
    Springler A; Hessenberger S; Schatzmayr G; Mayer E
    Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27618100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism.
    Pinton P; Braicu C; Nougayrede JP; Laffitte J; Taranu I; Oswald IP
    J Nutr; 2010 Nov; 140(11):1956-62. PubMed ID: 20861219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of deoxynivalenol-induced endocytosis and degradation of tight junction proteins in jejunal IPEC-J2 cells involve selective activation of the MAPK pathways.
    Li E; Horn N; Ajuwon KM
    Arch Toxicol; 2021 Jun; 95(6):2065-2079. PubMed ID: 33847777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application.
    Diesing AK; Nossol C; Dänicke S; Walk N; Post A; Kahlert S; Rothkötter HJ; Kluess J
    PLoS One; 2011 Feb; 6(2):e17472. PubMed ID: 21364771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontoxic concentrations of OTA aggravate DON-induced intestinal barrier dysfunction in IPEC-J2 cells via activation of NF-κB signaling pathway.
    Ying C; Hong W; Nianhui Z; Chunlei W; Kehe H; Cuiling P
    Toxicol Lett; 2019 Sep; 311():114-124. PubMed ID: 31026484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
    Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
    Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxynivalenol and its metabolite deepoxy-deoxynivalenol: multi-parameter analysis for the evaluation of cytotoxicity and cellular effects.
    Springler A; Hessenberger S; Reisinger N; Kern C; Nagl V; Schatzmayr G; Mayer E
    Mycotoxin Res; 2017 Feb; 33(1):25-37. PubMed ID: 27817099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Deoxynivalenol and Mycotoxin Adsorbent Agents on Mitogen-Activated Protein Kinase Signaling Pathways and Inflammation-Associated Gene Expression in Porcine Intestinal Epithelial Cells.
    Yu YH; Lai YH; Hsiao FS; Cheng YH
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33922863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases.
    Pinton P; Tsybulskyy D; Lucioli J; Laffitte J; Callu P; Lyazhri F; Grosjean F; Bracarense AP; Kolf-Clauw M; Oswald IP
    Toxicol Sci; 2012 Nov; 130(1):180-90. PubMed ID: 22859312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets.
    Li E; Li C; Horn N; Ajuwon KM
    Toxicol Lett; 2023 Feb; 375():8-20. PubMed ID: 36596350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis.
    De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Mixture Effects of Cereulide and Deoxynivalenol on Intestinal Barrier Integrity and Uptake in Differentiated Human Caco-2 Cells.
    Beisl J; Varga E; Braun D; Warth B; Ehling-Schulz M; Del Favero G; Marko D
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33806705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37.
    Tatsuta M; Kan-O K; Ishii Y; Yamamoto N; Ogawa T; Fukuyama S; Ogawa A; Fujita A; Nakanishi Y; Matsumoto K
    Respir Res; 2019 Nov; 20(1):251. PubMed ID: 31706310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and cyclosporine A alter barrier function in renal proximal tubular cells through stimulation of ERK1/2 signaling and claudin-1 expression.
    Martin-Martin N; Ryan G; McMorrow T; Ryan MP
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F672-82. PubMed ID: 19955189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2.
    Diesing AK; Nossol C; Panther P; Walk N; Post A; Kluess J; Kreutzmann P; Dänicke S; Rothkötter HJ; Kahlert S
    Toxicol Lett; 2011 Jan; 200(1-2):8-18. PubMed ID: 20937367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxynivalenol, but not E. coli lipopolysaccharide, changes the response pattern of intestinal porcine epithelial cells (IPEC-J2) according to its route of application.
    Kluess JW; Kahlert S; Kröber A; Diesing AK; Rothkötter HJ; Wimmers K; Dänicke S
    Toxicol Lett; 2015 Dec; 239(3):161-71. PubMed ID: 26417708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPARγ dependent and independent pathways in jejunal IPEC-J2 cells.
    Li E; Horn N; Ajuwon KM
    Food Res Int; 2022 Jul; 157():111420. PubMed ID: 35761666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontoxic-dose deoxynivalenol aggravates lipopolysaccharides-induced inflammation and tight junction disorder in IPEC-J2 cells through activation of NF-κB and LC3B.
    Ge L; Lin Z; Le G; Hou L; Mao X; Liu S; Liu D; Gan F; Huang K
    Food Chem Toxicol; 2020 Nov; 145():111712. PubMed ID: 32877744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 mitogen-activated protein kinase mediates downregulation of intestinal tight junction proteins in heat stress-induced IBD model in pig.
    Yong Y; Li J; Gong D; Yu T; Wu L; Hu C; Liu X; Yu Z; Ma X; Gooneratne R; Abd El-Aty AM; Chen J; Ju X
    J Therm Biol; 2021 Oct; 101():103103. PubMed ID: 34879918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice.
    Akbari P; Braber S; Alizadeh A; Verheijden KA; Schoterman MH; Kraneveld AD; Garssen J; Fink-Gremmels J
    J Nutr; 2015 Jul; 145(7):1604-13. PubMed ID: 26019243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.